DNA methylation patterns predict treatment response in MDS patients
DNA methylation patterns present at diagnosis could help predict which patients with myelodysplastic syndromes (MDS) will respond to azacitidine.
Read original article on The Medical News →Related news
-
Most eligible teens miss out on advanced obesity treatments
United Kingdom
-
AI analysis of ECG data measured by smartwatch may help detect reduced heart pumping function
United Kingdom
-
Complex procedure offers relief for children with chronic pancreatitis
United Kingdom
-
Phage protein study opens new path for future antibiotics
United Kingdom
-
UCLA study identifies lipid imbalance as pulmonary fibrosis trigger
United Kingdom
-
Rutgers receives grant to explore drug overdose trends among youth
United Kingdom
-
Slow hands, quiet nights? Tai chi and a matched exercise class nudged sleep about equally in older men after cancer
United Kingdom
-
Study highlights the need for better nutrition tracking in NICUs
United Kingdom